Atherosclerosis: Cell biology and lipoproteins. C-reactive protein is a biomarker of atherosclerosis and mediator of plaque formation

Current Opinion in Lipidology

Volumn 15, Issue 5, 2004, Pages 623-625

  Mukherjee, Sagarika ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR INFLAMMATION; CELL MIGRATION; CELL PROLIFERATION; CYTOLOGY; EDITORIAL; HUMAN; IN VIVO STUDY; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL;

EID: 5044240639     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200410000-00020     Document Type: Editorial

References (11)

1. Larigauderie G, Furman C, Jaye M, et al. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol 2004; 24:504-510.
2. Li SH, Szmitko PE, Weisel RD, et al. C-reactive protein upregulates complement inhibitory factors in endothelial cells. Circulation 2004; 109:833-836.
3. Pasceri V, Cheng JS, Willerson JT, et al. Modulation of c-reactive protein mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103:2531-2534.
4. Paul A, Ko KWS, Li L, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein e-deficient mice. Circulation 2004; 109:647-655
5. Nagoshi Y, Kuwasako K, Cao YN, et al. Effects of C-reactive protein on atherogenic mediators and adrenomedullin in human coronary artery endothelial and smooth muscle cells. Biochem Biophys Res Commun 2004; 314:1057-1063.
6. Sobel BE. Increased PAI-1 and vasculopathy: a reconcilable paradox. Circulation 1999; 99:2496-2498.
7. Dwyer JH, Paul-Labrador MJ, Fan J, et al. Progression of carotid intima media thickness and plasma antioxidants: The Los Angeles atherosclerosis study. Arterioscler Thromb Vasc Biol 2004; 24:313-319.
8. Rosenson RS. Statins in atherosclerosis: lipid lowering agents with antioxidants capabilities. Atherosclerosis 2004; 173:1-12.
9. Hulthe J, Fagerberg B. Circulating oxidised LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002; 22:1162-1167.
10. Yasojima K, Schwab C, McGeer EG, et al. Generation of C reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158:1039-1057.
11. Torzewski J, Torzewski M, Bower DE, et al. C-reactive protein frequently colocalises with terminal complememt complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18:1386-1392.